16 Mar

We worked at triple speed on vaccine patent strategy to help the world, says BioNTech IP chief

In an exclusive interview, BioNTech’s two most senior IP decision-makers, James Ryan and Julie Anne Gillespie, tell IAM about their life-changing experiences over the past year

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth